TrianglePUBLICATIONS · 22508822
Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2012 May 20
- First author
- Tap WD
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Tap WD
- type
- Author
- name
- Demetri G
- type
- Author
- name
- Barnette P
- type
- Author
- name
- Desai J
- type
- Author
- name
- Kavan P
- type
- Author
- name
- Tozer R
- type
- Author
- name
- Benedetto PW
- type
- Author
- name
- Friberg G
- type
- Author
- name
- Deng H
- type
- Author
- name
- McCaffery I
- type
- Author
- name
- Leitch I
- type
- Author
- name
- Badola S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Tap WD
- type
- Author
- name
- Demetri G
- type
- Author
- name
- Barnette P
- type
- Author
- name
- Desai J
- type
- Author
- name
- Kavan P
- type
- Author
- name
- Tozer R
- type
- Author
- name
- Benedetto PW
- type
- Author
- name
- Friberg G
- type
- Author
- name
- Deng H
- type
- Author
- name
- McCaffery I
- type
- Author
- name
- Leitch I
- type
- Author
- name
- Badola S
- type
- Author
- bibliography ids
- nci-bib-f1772aea0bb901e7eec97925
- book metadata
- content sha256
- 89936caa4b5328524d0152a552dd390124a5758c51ba079b44688a177ffbe765
- document type
- citation
- dois
- 10.1200/JCO.2011.37.2359
- electronic publication date
- display
- 2012 Apr 16
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22508822
- immutable id
- pubmed:22508822@89936caa4b5328524d0152a552dd390124a5758c51ba079b44688a177ffbe765
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 15
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1849-56
- volume
- 30
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22508822
- provenance
- batch id
- c95be1d0b8cf19942816
- provider
- NCBI PubMed ESummary
- record sha256
- 810d998e683b295176bc7cdf06bd95604f1fab02bd56f950493852d2bc30baac
- response sha256
- a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
- retrieved at
- 2026-09-09T23:46:47.691937+00:00
- publication date
- display
- 2012 May 20
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors.
Preserved source evidence · Not medical advice